A UK vaccine center is on the market and fielding offers from manufacturing giants
Just three years after the UK government announced the creation of the VMIC as a part of a plan to develop and make vaccines in preparation for a potential pandemic, the flagship center is up for sale.
Several companies have submitted bids for the center, which is located near Oxford. Construction was set to be completed in 2023 but was later pushed up to spring 2022. The site has received more than £200 million in public funding throughout the pandemic, but need for a state-backed manufacturing center has lessened, as companies have stepped up to meet the growing demand for vaccines.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 129,600+ biopharma pros reading Endpoints daily — and it's free.